Kay MA - Search Results

1

Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo.

Paulk NK, Wursthorn K, Wang Z, Finegold MJ, Kay MA, Grompe M. Paulk NK, et al. Among authors: kay ma. Hepatology. 2010 Apr;51(4):1200-8. doi: 10.1002/hep.23481. Hepatology. 2010. PMID: 20162619 Free PMC article.

2

Hepatic gene therapy: persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo.

Kay MA, Li Q, Liu TJ, Leland F, Toman C, Finegold M, Woo SL. Kay MA, et al. Hum Gene Ther. 1992 Dec;3(6):641-7. doi: 10.1089/hum.1992.3.6-641. Hum Gene Ther. 1992. PMID: 1482704

3

Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes.

Kay MA, Graham F, Leland F, Woo SL. Kay MA, et al. Hepatology. 1995 Mar;21(3):815-9. Hepatology. 1995. PMID: 7875680

4

Hepatic gene therapy: efficient retroviral-mediated gene transfer into rat hepatocytes in vivo.

Kolodka TM, Finegold M, Kay MA, Woo SL. Kolodka TM, et al. Among authors: kay ma. Somat Cell Mol Genet. 1993 Sep;19(5):491-7. doi: 10.1007/BF01233254. Somat Cell Mol Genet. 1993. PMID: 7980740

5

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.

Kay MA, Landen CN, Rothenberg SR, Taylor LA, Leland F, Wiehle S, Fang B, Bellinger D, Finegold M, Thompson AR, et al. Kay MA, et al. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2353-7. doi: 10.1073/pnas.91.6.2353. Proc Natl Acad Sci U S A. 1994. PMID: 8134398 Free PMC article.

6

In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs.

Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, Thompson AR, Read MS, Brinkhous KM, et al. Kay MA, et al. Science. 1993 Oct 1;262(5130):117-9. doi: 10.1126/science.8211118. Science. 1993. PMID: 8211118

7

Assessment of recombinant adenoviral vectors for hepatic gene therapy.

Li Q, Kay MA, Finegold M, Stratford-Perricaudet LD, Woo SL. Li Q, et al. Among authors: kay ma. Hum Gene Ther. 1993 Aug;4(4):403-9. doi: 10.1089/hum.1993.4.4-403. Hum Gene Ther. 1993. PMID: 8399487

8

Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I.

Overturf K, al-Dhalimy M, Ou CN, Finegold M, Tanguay R, Lieber A, Kay M, Grompe M. Overturf K, et al. Hum Gene Ther. 1997 Mar 20;8(5):513-21. doi: 10.1089/hum.1997.8.5-513. Hum Gene Ther. 1997. PMID: 9095403

9

In vivo correction of murine tyrosinemia type I by DNA-mediated transposition.

Montini E, Held PK, Noll M, Morcinek N, Al-Dhalimy M, Finegold M, Yant SR, Kay MA, Grompe M. Montini E, et al. Among authors: kay ma. Mol Ther. 2002 Dec;6(6):759-69. doi: 10.1006/mthe.2002.0812. Mol Ther. 2002. PMID: 12498772 Free article.

10

Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice.

Nakai H, Montini E, Fuess S, Storm TA, Meuse L, Finegold M, Grompe M, Kay MA. Nakai H, et al. Among authors: kay ma. Mol Ther. 2003 Jan;7(1):101-11. doi: 10.1016/s1525-0016(02)00023-0. Mol Ther. 2003. PMID: 12573623 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

308 results

Search Page

Filters